Objective  To investigate the efficacy and safety of Huoluoxiaolingdan formula combined with ginkgolide injection in the treatment of ischemic stroke patients with blood stasis blockage syndrome.

Methods  The ischemic stroke patients with blood stasis blockage syndrome who were treated in Suzhou First People's Hospital from June 2017 to August 2019 were randomly divided into test group and control group. The control group was given ginkgolide injection, and the test group was given Huoluoxiaolingdan formula additionally. Both groups were treated for 2 weeks. The efficacy and adverse drug reactions of the two groups were evaluated, and the changes of clinical scores, hemorheology, blood lipids and inflammatory factors before and after treatment were compared between the two groups.

Results  A total of 194 patients were included, there were 97 cases in each group. The total effective rate of test group was 91.75%, which was significantly higher than that of control group (79.38%) (P<0.05), and the incidence of adverse reactions was significantly lower than that in the control group (P<0.05). After treatment, NIHSS, CSS and ASS in both groups were lower than before treatment (P<0.05), while BI was higher than before treatment (P<0.05). The levels of ηp, ηb, Fib and EEP in test group were significantly lower than those in control group (P<0.05). HDL-C level of test group was significantly higher than that of control group, TC, LDL-C and TG levels were lower than that of control group (P<0.05). The levels of IL-4 in test group were significantly higher than those in control group, and the levels of IL^-1β, IL-8 and TNF-α were lower than those in control group (P<0.05). The above indexes in the test group was significantly better than that in control group (P<0.05).

Conclusion  Huoluoxiaolingdan formula combined with ginkgolide injection can significantly improve the efficacy of patients with blood stasis blockage syndrome during the recovery period of ischemic stroke, improve clinical symptom score, correct abnormal hemorheology, reduce blood lipid level, inhibit the progression of inflammation, and alleviate adverse reactions, which has high clinical application value.

1.Xia Y, Liu H, Zhu R. Risk factors for stroke recurrence in young patients with first-ever ischemic stroke: a meta-analysis[J]. World J Clin Cases, 2023, 11(26): 6122-6131. DOI: 10.12998/wjcc.v11.i26.6122.

2.Zhang Y, Song Q, Wang Y, et al. Neuroprotective effect of aspirin combined with ginkgolide injection on cerebral ischemic stroke rats and its effect on ERK12 signal pathway[J]. Saudi J Biol Sci, 2021, 28(6): 3193-3197. DOI: 10.1016/j.sjbs.2021.04.017.

3.郭雯, 郭建辉, 邢雅娟, 等. 活络效灵丹加味方治疗血瘀型银屑病的效果及对血液流变学和血浆内皮素的影响[J]. 浙江中医药大学学报, 2023, 47(2): 184-189. [Guo W, Guo JH, Xing YJ. Effect of revised Huoluo Xiaoling pill on blood stasis psoriasis and its effect on hemorheology and plasma endothelin level[J]. Journal of Zhejiang Chinese Medicine University, 2019, 47(2): 184-189.] DOI: 10.16466/j.issn1005-5509.2023.02.014.

4.中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682. DOI: 10.3760/cma.j.issn.1006-7876.2018.09.004.

5.国家中医药管理局. 中药新药临床研究指导原则[S]. 2002.

6.王瑞平. 随机对照临床试验设计中的样本量估算方法 [J]. 上海医药, 2023, 44(1): 48-52. [Wang RP. Sample size estimation in randomized controlled clinical trial design[J]. Shanghai Medical & Pharmaceutical Journal, 2019, 44(1): 48-52.] DOI: 10.3969/j.issn.1006-1533. 2023.01.013.

7.Sharma D, Aravind S, Joseph S, et al. The role of monocyte to high-density lipoprotein cholesterol ratio in predicting the severity of acute ischemic stroke and its association with the NIHSS[J]. J Assoc Physicians India, 2023, 71(8): 11-12. DOI: 10.59556/japi.71.0321.

8.Danielis M, Bortot S, Zanotti R. Comparison between the general assessment of hospitalised patient tool and the barthel index: A retrospective study[J]. Nurs Rep, 2023, 13(3): 1160-1169. DOI: 10.3390/nursrep13030100.

9.蔡增印, 张莉婷. 急性脑梗死患者采取银杏二萜内酯葡胺与奥扎格雷联合治疗方案的效果及对CSS评分的影响[J]. 贵州医药, 2022, 46(2): 251-252. [Cai ZY, Zhang LT. Effect of combination therapy of ginkgo diterpene lactone meglumine and ozgrel on CSS score in patients with acute cerebral infarction[J]. Guizhou Medical Journal, 2022, 46(2): 251-252.] DOI: 10.3969/j.issn.1000-744X.2022.02.048.

10.Vidmar T, Goljar KN, Puh U. Reliability of the modified ashworth scale after stroke for 13 muscle groups[J]. Arch Phys Med Rehabil, 2023, 104(10): 1606-1611. DOI: 10.1016/j.apmr.2023.04.008.

11.Y MR, Murthy JM, Y SR, et al. First-ever ischemic stroke in Covid-19: how is it different? - a stroke registry-based study from South India[J]. Acta Neurol Taiwan, 2023, 32(4): 190-201. https://pubmed.ncbi.nlm.nih.gov/37723911/.

12.Li J, Jiang W, Cai Y, et al. Astrocytic endothelin-1 overexpression impairs learning and memory ability in ischemic stroke via altered hippocampal neurogenesis and lipid metabolism[J]. Neural Regen Res, 2024, 19(3): 650-656. DOI: 10.4103/1673-5374.380906.

13.Li Y, Li M, Feng S, et al. Ferroptosis and endoplasmic reticulum stress in ischemic stroke[J]. Neural Regen Res, 2024, 19(3): 611-618. DOI: 10.4103/1673-5374.380870.

14.Xie X, Wang L, Dong S, et al. Immune regulation of the gut-brain axis and lung-brain axis involved in ischemic stroke[J]. Neural Regen Res, 2024, 19(3): 519-528. DOI: 10.4103/1673-5374.380869.

15.王巍, 高会文, 霍琰梅, 等. 早期精准化运动康复对急性缺血性脑卒中偏瘫患者血清细胞因子及步行能力的影响[J]. 中国实用神经疾病杂志, 2023, 26(10): 1275-1280. [Wang W, Gao HW, Huo YM, et al. Effect of early precision exercise rehabilitation on the levels of serum cytokine and walking ability in patients with hemiplegia after acute ischemic stroke[J]. Chinese Journal of Practical Nervous Diseases, 2023, 26(10): 1275-1280.] DOI: 10.12083/SYSJ.230911.

16.张奇先, 丁爽, 吴前. 活络效灵丹对大鼠膝骨关节炎的修复作用及机制[J]. 解剖科学进展, 2022, 28(3): 319-322. [Zhang QX, Ding S, Wu Q. Repair effect and mechanism of Huo-Luo-Xiao-Ling Dan on knee osteoarthritis in rats[J]. Progress of Anatomical Sciences, 2022, 28(3): 319-322.] DOI: 10.16695/j.cnki.1006-2947. 2022.03.020.

17.李沿鑫, 王爱国, 陆贲琪, 等. 基于网络药理学和分子对接探讨活络效灵丹治疗骨关节炎的作用机制[J]. 现代药物与临床, 2022, 37(4): 708-718. [Li YX, Wang AG, Lu BQ, et al. Mechanism of Huoluoxiaoling Pills in treatment of osteoarthritis based on network pharmacology and molecular docking[J]. Drugs & Clinic, 2022, 37(4): 708-718.] DOI: 10.7501/j.issn.1674-5515.2022.04.006.

18.李志明, 姜家旺, 周瑞生, 等. 加味活络效灵丹促进空腔脏器肿瘤排出体外的理论与机制探讨[J]. 江西中医药大学学报, 2022, 34(1): 6-10. [Li ZM, Jiang JW, Zhou RS, et al. Study on the theory and mechanism of Jiawei Huoluoxiaolingdan in promoting tumor excretion of cavity organs[J]. Journal of Jiangxi University of Chinese Medicine, 2022, 34(1): 6-10.] https://d.wanfangdata.com.cn/periodical/jxzyxyxb202201003.

19.朱千三. 活络效灵丹加味颗粒剂治疗精索静脉曲张疼痛的效果观察及对负性情绪的调节作用[J]. 中国中医药科技, 2022, 29(6): 1090-1092. [Zhu QS. Effect of Huoluoxiaolingdan Jiawei Granules in the treatment of varicocele pain and its regulating effect on negative emotions[J]. Chinese Science and Technology of Traditional Chinese Medicine, 2022, 29(6): 1090-1092.] https://www.cnki.com.cn/Article/CJFDTotal-TJYY202206064.htm.

20.郭建辉, 郭雯, 邢雅娟, 等. 活络效灵丹加味方治疗血瘀型银屑病临床研究[J]. 陕西中医, 2022, 43(11): 1544-1546, 1550. [Guo JH, Guo W, Xing YJ, et al. Clinical study on Huoluoxiao-Lingdan Jiawei prescription in the treatment of blood stasis psoriasis[J]. Shaanxi Journal of Traditional Chinese Medicine, 2022, 43(11): 1544-1546, 1550.] DOI: 10.3969/j.issn.1000-7369.2022.11.012.

21.欧阳云, 刘正立, 徐春龙, 等. 活络效灵丹通过激活磷脂酰肌醇3激酶/蛋白激酶B信号通路降低青光眼兔视神经损伤的研究[J]. 河北中医, 2020, 42(5): 737-744. [Ouyang Y, Liu ZL, Xu CL. Effect of Huoluoxiaolingdan on reducing optic nerve injury in glaucoma rabbits by activating phosphatidyli-nositol 3- kinase / protein kinase signaling pathway[J]. Hebei Journal of Traditional Chinese Medicine, 2020, 42(5): 737-744.] DOI: 10.3969/j.issn.1002-2619.2020.05.021.

22.Yu X, Liu X, Mi X, et al. Jionoside A1 alleviates ischemic stroke ischemia/reperfusion injury by promoting Nix-mediated mitophagy[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(8): 237-245. DOI: 10.14715/cmb/2023.69.8.37.

23.郭鹤, 郑一, 于嘉祥, 等. 基于网络药理学探讨活络效灵丹治疗冠心病的作用机制[J]. 辽宁中医杂志, 2021, 48(10): 143-149. [Guo H, Zheng Y, Yu JX, et al. Study on mechanism of huoluoxiaolingdan treating coronary heart disease based on network pharmacology[J].Liaoning Journal of Traditional Chinese Medicine, 2021, 48(10): 143-149.] DOI: 10.13192/j.issn.1000-1719.2021.10.039.

24.Malikova H, Kremenova K, Lukavsky J, et al. Early and late infarct growth rate in ischemic stroke patients after successful endovascular treatment in early time window: correlation of imaging and clinical factors with clinical outcome[J]. Quant Imaging Med Surg, 2023, 13(9): 5770-5782. DOI: 10.21037/qims-23-153.

25.Han S, Yu X, Wang R, et al. Tanshinone IIA inhibits cell viability and promotes PUMA-mediated apoptosis of oral squamous cell carcinoma[J]. J Cancer, 2023, 14(13): 2481-2490. DOI: 10.7150/jca.84537.

26.Urabe F, Iwatani K, Hashimoto M, et al. Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case series[J]. Transl Androl Urol, 2023,12(8): 1321-1325. DOI: 10.21037/tau-23-203.

27.Zhu Y, Shan X, Zhou J, et al. Complete genome sequence of pythium oligandrum, isolated from rhizosphere soils of Chinese Angelica sinensis[J]. Mol Plant Microbe Interact, 2022, 35(12): 1127-1130. DOI: 10.1094/MPMI-04-22-0091-A.

28.Menghan LI, Yan Y, Shizhe D, et al. Contralateral needling at the foot of unaffected side combining with rehabilitation treatment for motor dysfunction of hand after ischemic stroke: study protocol for a randomized controlled pilot trial[J]. J Tradit Chin Med, 2023, 43(5): 1034-1039. DOI: 10.19852/j.cnki.jtcm.2023.05.007.

29.徐勤, 王朝华, 游三丽, 等. 丹参酮IIA减轻氧糖剥夺诱导心肌细胞损伤的机制[J]. 中南大学学报(医学版), 2023, 48(3): 369-375. [Xu Q, Wang ZH, You SL, et al. Mechanism for effect of tanshinone ⅡA on alleviating cardiomyocyte injury induced by oxygen glucose deprivation[J]. Journal of Central South University (Medical Science), 2023, 48(3): 369-375.] DOI: 10.11817/j.issn. 1672-7347.2023.220173.

30.袁蕾, 苗芳元, 张梦琳, 等. 血清PUFA水平与脑梗死患者总胆固醇、甘油三酯、LDL-C及HDL-C水平及预后的关系[J]. 临床和实验医学杂志, 2023, 22(7): 685-689. [Yuan L, Miao FY, Zhang ML. Relationship between serum PUFA level and total cholesterol,triglyceride,LDL-C,HDL-C levels and prognosis of patients with cer-ebral infarction[J]. Journal of Clinical and Experimental Medicine, 2023, 22(7): 685-689.] DOI: 10.3969/j.issn.1671-4695.2023.07.004.